Trupanion, Inc. (NASDAQ:TRUP) Accelerates After Tech Signals Favor Near-Term Upside

Momentum and operational metrics point to a cautiously constructive near-term path for the shares, underpinned by improving technical momentum and stable cash generation. Fundamentals show mixed progress across margins and growth that should shape market reaction over the next quarter.

Recent News

On May 26, 2026 Trupanion announced it surpassed $4.0 billion in paid claims, highlighting accelerated claims growth and expanded VetDirect Pay adoption. On June 18, 2026 the company announced winners of its 2026 Veterinary Appreciation Day Awards, recognizing veterinary teams and individuals for clinical and community contributions.

Technical Analysis

ADX registers 28.89, indicating a strong trend in place and lending strength to directional signals.

DI+ at 35.47 trends increasing while DI- at 15.45 trends decreasing, a bullish directional configuration that favors upward price pressure relative to downside pressure.

MACD reads 1.25 with the MACD trend increasing and the signal line at 0.77; MACD sits above its signal line, producing a bullish momentum confirmation.

MRO registers 2.53 and trends increasing; the positive MRO indicates price currently stands above the model target, creating potential downward reversion pressure into any near-term stretch.

RSI at 56.54 trends increasing, implying constructive momentum without overbought extremes.

Price sits at $29.99, above the 20-day average ($27.53) and 50-day average ($25.59), and slightly above the 200-day average ($29.32); the 12-day EMA ($28.60) trends higher, reinforcing near-term upward bias while the super trend lower at $27.70 acts as an intraday structural support reference.

Bollinger bands show a 1x upper band near $30.53 and a 2x upper band near $33.54, framing the short-term volatility corridor; trading volume on the latest session (610,818) falls below the 10-day average (774,807), suggesting recent moves lack elevated participation.

 


Fundamental Analysis

Revenue reached $392,934,000 with revenue growth year-over-year at 2.31% and quarter-over-quarter revenue growth at 21.22%, signaling sequential acceleration in top-line activity.

Operating income of $29,181,000 yields an operating margin of 7.43%, with operating margin improving 4.14 percentage points QoQ and up 18.49% YoY on a relative basis. EBIT totals $9,205,000 and produces an EBIT margin of 2.34%; that EBIT margin sits below the industry peer mean of 8.28% and below the industry peer median of 7.03%.

Net income reached $6,831,000 with EPS of $0.86 versus an estimate of $0.94, producing an EPS surprise of -8.51% on the report dated 2026-08-05 (period ending 2026-06-30). Forward EPS stands at $1.065, with a forward P/E of 22.85 while the trailing P/E reads 29.18.

Cash and short-term investments total $398,491,000 and cash registers $149,360,000; operating cash flow reached $20,984,000 with free cash flow at $19,159,000 and a free cash flow yield of 1.74%. Cash conversion ratio registers 1.25, and cash conversion cycle days measure 66.97 days.

Leverage metrics show total debt at $106,909,000, debt-to-equity at 0.26 and debt-to-EBITDA at 8.30; interest coverage stands at 5.02x. Asset turnover sits at 0.424, above the industry peer mean of 0.0369, indicating relatively higher revenue generation per asset dollar.

Book value per share reads $9.34 while price-to-book at 2.69 sits above the industry peer mean of 1.97 and near the industry peer median of 2.05. The price-to-sales ratio of 2.80 sits slightly below the industry peer mean of 3.07 and below the industry peer median of 2.97. WMDST values the stock as fair-valued based on the current mix of cash flow, margins, and multiples.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-06-30
REPORT DATE: 2026-08-05
NEXT REPORT DATE: 2026-11-04
CASH FLOW  Begin Period Cash Flow 182.9 M
 Operating Cash Flow 21.0 M
 Capital Expenditures -1.82 M
 Change In Working Capital 676.0 K
 Dividends Paid
 Cash Flow Delta -4.57 M
 End Period Cash Flow 178.3 M
 
INCOME STATEMENT REVENUE
 Total Revenue 392.9 M
 Forward Revenue 671.9 M
COSTS
 Cost Of Revenue 327.8 M
 Depreciation 3.7 M
 Depreciation and Amortization 3.7 M
 Research and Development 12.8 M
 Total Operating Expenses 363.8 M
PROFITABILITY
 Gross Profit 65.1 M
 EBITDA 12.9 M
 EBIT 9.2 M
 Operating Income 29.2 M
 Interest Income
 Interest Expense 1.8 M
 Net Interest Income -1.83 M
 Income Before Tax 7.4 M
 Tax Provision 542.0 K
 Tax Rate 7.351 %
 Net Income 6.8 M
 Net Income From Continuing Operations 6.8 M
EARNINGS
 EPS Estimate 0.94
 EPS Actual 0.86
 EPS Difference -0.08
 EPS Surprise -8.511 %
 Forward EPS 1.06
 
BALANCE SHEET ASSETS
 Total Assets 930.8 M
 Intangible Assets 62.0 M
 Net Tangible Assets 347.7 M
 Total Current Assets 719.4 M
 Cash and Short-Term Investments 398.5 M
 Cash 149.4 M
 Net Receivables 302.2 M
 Inventory
 Long-Term Investments 47.0 M
LIABILITIES
 Accounts Payable 12.0 M
 Short-Term Debt 10.0 M
 Total Current Liabilities 405.5 M
 Net Debt
 Total Debt 106.9 M
 Total Liabilities 521.1 M
EQUITY
 Total Equity 409.7 M
 Retained Earnings -194.74 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 9.34
 Shares Outstanding 43.872 M
 Revenue Per-Share 8.96
VALUATION
 Market Capitalization 1.1 B
 Enterprise Value 809.5 M
 Enterprise Multiple 62.863
Enterprise Multiple QoQ -24.112 %
Enterprise Multiple YoY -38.65 %
Enterprise Multiple IPRWA
 EV/R 2.06
CAPITAL STRUCTURE
 Asset To Equity 2.272
 Asset To Liability 1.786
 Debt To Capital 0.207
 Debt To Assets 0.115
Debt To Assets QoQ -3.194 %
Debt To Assets YoY -14.931 %
Debt To Assets IPRWA high: 1.713
TRUP: 0.115
mean: 0.049
low: 0.028
median: 0.028
 Debt To Equity 0.261
Debt To Equity QoQ -5.774 %
Debt To Equity YoY -18.964 %
Debt To Equity IPRWA high: 1.002
median: 0.778
mean: 0.723
TRUP: 0.261
low: -1.457
PRICE-BASED VALUATION
 Price To Book (P/B) 2.688
Price To Book QoQ -13.722 %
Price To Book YoY -53.823 %
Price To Book IPRWA high: 5.389
TRUP: 2.688
median: 2.046
mean: 1.97
low: -0.132
 Price To Earnings (P/E) 29.185
Price To Earnings QoQ -19.269 %
Price To Earnings YoY -86.767 %
Price To Earnings IPRWA high: 36.226
median: 36.226
TRUP: 29.185
mean: 26.44
low: -570.283
 PE/G Ratio 2.846
 Price To Sales (P/S) 2.802
Price To Sales QoQ -12.501 %
Price To Sales YoY -52.113 %
Price To Sales IPRWA high: 3.356
mean: 3.07
low: 2.974
median: 2.974
TRUP: 2.802
FORWARD MULTIPLES
Forward P/E 22.853
Forward PE/G 2.228
Forward P/S 1.62
EFFICIENCY OPERATIONAL
 Operating Leverage 7.584
ASSET & SALES
 Asset Turnover Ratio 0.424
Asset Turnover Ratio QoQ 1.444 %
Asset Turnover Ratio YoY 1.094 %
Asset Turnover Ratio IPRWA TRUP: 0.424
high: 0.17
mean: 0.037
median: 0.025
low: 0.014
 Receivables Turnover 1.295
Receivables Turnover Ratio QoQ 2.272 %
Receivables Turnover Ratio YoY 6.731 %
Receivables Turnover Ratio IPRWA high: 4.728
TRUP: 1.295
mean: 0.759
median: 0.374
low: 0.162
 Inventory Turnover
Inventory Turnover Ratio QoQ
Inventory Turnover Ratio YoY
Inventory Turnover Ratio IPRWA
 Days Sales Outstanding (DSO) 70.479
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 66.973
Cash Conversion Cycle Days QoQ -1.217 %
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA high: 564.398
mean: 262.832
median: 244.041
TRUP: 66.973
low: 19.299
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 1.252
 CapEx To Revenue -0.005
 CapEx To Depreciation -0.497
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 506.6 M
 Net Invested Capital 516.6 M
 Invested Capital 516.6 M
 Net Tangible Assets 347.7 M
 Net Working Capital 314.0 M
LIQUIDITY
 Cash Ratio 0.983
 Current Ratio 1.774
Current Ratio QoQ 2.75 %
Current Ratio YoY 5.003 %
Current Ratio IPRWA
 Quick Ratio
Quick Ratio QoQ
Quick Ratio YoY
Quick Ratio IPRWA
COVERAGE & LEVERAGE
 Debt To EBITDA 8.302
 Cost Of Debt 1.57 %
 Interest Coverage Ratio 5.025
Interest Coverage Ratio QoQ 20.305 %
Interest Coverage Ratio YoY 30.028 %
Interest Coverage Ratio IPRWA high: 7.212
mean: 5.072
TRUP: 5.025
median: 4.545
low: 0.122
 Operating Cash Flow Ratio 0.03
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 3.507
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 1.002 %
 Revenue Growth 2.314 %
Revenue Growth QoQ 21.215 %
Revenue Growth YoY -31.68 %
Revenue Growth IPRWA high: 26.976 %
mean: 7.231 %
TRUP: 2.314 %
low: 1.402 %
median: 1.402 %
 Earnings Growth 10.256 %
Earnings Growth QoQ -97.949 %
Earnings Growth YoY -101.231 %
Earnings Growth IPRWA high: 56.391 %
mean: 12.975 %
TRUP: 10.256 %
median: 0.413 %
low: -50.0 %
MARGINS
 Gross Margin 16.576 %
Gross Margin QoQ 3.529 %
Gross Margin YoY 6.894 %
Gross Margin IPRWA
 EBIT Margin 2.343 %
EBIT Margin QoQ 14.909 %
EBIT Margin YoY -41.774 %
EBIT Margin IPRWA high: 22.222 %
mean: 8.278 %
median: 7.03 %
TRUP: 2.343 %
low: 1.125 %
 Return On Sales (ROS) 7.426 %
Return On Sales QoQ 4.137 %
Return On Sales YoY 18.494 %
Return On Sales IPRWA
CASH FLOW
 Free Cash Flow (FCF) 19.2 M
 Free Cash Flow Yield 1.74 %
Free Cash Flow Yield QoQ 55.635 %
Free Cash Flow Yield YoY 198.969 %
Free Cash Flow Yield IPRWA high: 13.923 %
mean: 5.83 %
median: 3.969 %
TRUP: 1.74 %
low: -1.307 %
 Free Cash Growth 39.369 %
Free Cash Growth QoQ -186.056 %
Free Cash Growth YoY -378.108 %
Free Cash Growth IPRWA high: 1792.776 %
TRUP: 39.369 %
median: -17.082 %
mean: -61.153 %
low: -1070.642 %
 Free Cash To Net Income 2.805
 Cash Flow Margin 3.117 %
 Cash Flow To Earnings 1.793
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 0.738 %
Return On Assets QoQ 38.983 %
Return On Assets YoY -33.93 %
Return On Assets IPRWA high: 1.185 %
TRUP: 0.738 %
mean: 0.211 %
median: 0.098 %
low: -2.324 %
 Return On Capital Employed (ROCE) 1.752 %
 Return On Equity (ROE) 0.017
Return On Equity QoQ 34.871 %
Return On Equity YoY -37.047 %
Return On Equity IPRWA high: 0.039
mean: 0.029
median: 0.027
TRUP: 0.017
low: 0.001
 DuPont ROE 1.698 %
 Return On Invested Capital (ROIC) 1.651 %
Return On Invested Capital QoQ 29.694 %
Return On Invested Capital YoY -38.897 %
Return On Invested Capital IPRWA high: 3.101 %
mean: 2.233 %
median: 2.04 %
TRUP: 1.651 %
low: 0.555 %

Six-Week Outlook

Near-term technicals favor further consolidation to upside: directional indicators and MACD momentum suggest upward bias while positive MRO flags a measured risk of pullback toward model targets. Expect the stock to trade within the Bollinger-defined volatility band between roughly $27.7 (technical support) and $33.5 (upper volatility edge) absent a material fundamental surprise. Volume remaining below recent averages would limit breakout conviction, while any pickup in institutional participation would validate the existing bullish configuration. Watch quarterly cadence and any operational updates tied to VetDirect Pay scale or claims trends for catalysts that could alter the current pattern.

About Trupanion, Inc.

Trupanion, Inc. (NASDAQ:TRUP) delivers medical insurance solutions for cats and dogs through a monthly subscription model. Headquartered in Seattle, Washington, Trupanion caters to pet owners and veterinarians across the United States, Canada, Continental Europe, and Australia. The company divides its operations into two main segments: Subscription Business and Other Business. The Subscription Business segment provides pet owners with comprehensive coverage plans, while the Other Business segment offers additional services related to pet health and wellness. Founded in 2000, Trupanion initially operated under the name Vetinsurance International, Inc. before rebranding in 2013. Through its offerings, Trupanion aims to alleviate the financial burden of veterinary care, enabling pet owners to access necessary medical treatments for their pets without hesitation. By partnering with veterinary practices, Trupanion facilitates direct payments, streamlining the insurance process and enhancing the customer experience.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.